Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder

BACKGROUND: Epstein–Barr virus-associated post-transplant lymphoproliferative disorder (EBV-PTLD) is a potentially fatal complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Rituximab has been proven to dramatically improve the prognosis of patients with EBV reactivatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Nan, Wang, Na, Zhang, Peiling, Wang, Gaoxiang, Mao, Xia, Peng, Dan, Kuang, Dong, Chen, Liting, Zhu, Li, Zhou, Jianfeng, Zhang, Yicheng, Cao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339712/
https://www.ncbi.nlm.nih.gov/pubmed/34367995
http://dx.doi.org/10.3389/fonc.2021.709370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339712/
https://www.ncbi.nlm.nih.gov/pubmed/34367995
http://dx.doi.org/10.3389/fonc.2021.709370

Ejemplares similares